These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 18824225)
1. In situ precipitation and vacuum drying of interferon alpha-2a: development of a single-step process for obtaining dry, stable protein formulation. Kumar V; Sharma VK; Kalonia DS Int J Pharm; 2009 Jan; 366(1-2):88-98. PubMed ID: 18824225 [TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-induced precipitation of interferon alpha-2a followed by vacuum drying: development of a novel process for obtaining a dry, stable powder. Sharma VK; Kalonia DS AAPS PharmSci; 2004 Jan; 6(1):E4. PubMed ID: 15198505 [TBL] [Abstract][Full Text] [Related]
3. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Schüle S; Friess W; Bechtold-Peters K; Garidel P Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996 [TBL] [Abstract][Full Text] [Related]
4. Steady-state tryptophan fluorescence spectroscopy study to probe tertiary structure of proteins in solid powders. Sharma VK; Kalonia DS J Pharm Sci; 2003 Apr; 92(4):890-9. PubMed ID: 12661074 [TBL] [Abstract][Full Text] [Related]
5. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection. Liu D; Galvanin F; Yu Y AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380 [TBL] [Abstract][Full Text] [Related]
6. Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran. Allison SD; Manning MC; Randolph TW; Middleton K; Davis A; Carpenter JF J Pharm Sci; 2000 Feb; 89(2):199-214. PubMed ID: 10688749 [TBL] [Abstract][Full Text] [Related]
7. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Cleland JL; Jones AJ Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836 [TBL] [Abstract][Full Text] [Related]
9. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying. Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123 [TBL] [Abstract][Full Text] [Related]
10. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability. Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449 [TBL] [Abstract][Full Text] [Related]
11. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Anhorn MG; Mahler HC; Langer K Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043 [TBL] [Abstract][Full Text] [Related]
12. Protein Aggregation in Frozen Trehalose Formulations: Effects of Composition, Cooling Rate, and Storage Temperature. Connolly BD; Le L; Patapoff TW; Cromwell MEM; Moore JMR; Lam P J Pharm Sci; 2015 Dec; 104(12):4170-4184. PubMed ID: 26398200 [TBL] [Abstract][Full Text] [Related]
13. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024 [TBL] [Abstract][Full Text] [Related]
14. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state. Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086 [TBL] [Abstract][Full Text] [Related]
15. Stabilization of a recombinant human epidermal growth factor parenteral formulation through freeze-drying. Santana H; Sotolongo J; González Y; Hernández G; Chinea G; Gerónimo H; Amarantes O; Beldarraín A; Páez R Biologicals; 2014 Nov; 42(6):322-33. PubMed ID: 25190208 [TBL] [Abstract][Full Text] [Related]
16. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody. Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290 [TBL] [Abstract][Full Text] [Related]
17. Effect of molecular weight and ratio of poly ethylene glycols' derivatives in combination with trehalose on stability of freeze-dried IgG. Mohammad Zadeh AH; Rouholamini Najafabadi A; Vatanara A; Faghihi H; Gilani K Drug Dev Ind Pharm; 2017 Dec; 43(12):1945-1951. PubMed ID: 28689435 [TBL] [Abstract][Full Text] [Related]
18. Stability of lyophilized albumin formulations: Role of excipient crystallinity and molecular mobility. Jena S; Krishna Kumar NS; Aksan A; Suryanarayanan R Int J Pharm; 2019 Oct; 569():118568. PubMed ID: 31352055 [TBL] [Abstract][Full Text] [Related]
19. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study. Srinivasan JM; Wegiel LA; Hardwick LM; Nail SL J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201 [TBL] [Abstract][Full Text] [Related]
20. Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations. Zhang Y; Peng X; Zhang H; Watts AB; Ghosh D Int J Pharm; 2018 May; 542(1-2):1-7. PubMed ID: 29486286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]